Evidence map›Paper›PMID 34535212›Full record

ArticleZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

Effect of tacrolimus on the expression of Park7 in glomerular podocytes injured by puromycin aminonucleoside.

Jun-Jie Tan, Sheng-You Yu, Yao Zhang, Zhi-Hong Hao, Li Yu

Open access · greenAbstract read
In one paragraph

Article in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jun-Jie TanDepartment of Pediatrics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China (Yu L, Email: yuli828@yeah.net).
Sheng-You YuDepartment of Pediatrics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China (Yu L, Email: yuli828@yeah.net).
Yao ZhangDepartment of Pediatrics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China (Yu L, Email: yuli828@yeah.net).
Zhi-Hong HaoDepartment of Pediatrics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China (Yu L, Email: yuli828@yeah.net).
Li YuDepartment of Pediatrics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China (Yu L, Email: yuli828@yeah.net).
Guangzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo study the effect of puromycin aminonucleoside (PAN) on the apoptosis of mouse podocyte clone 5 (MPC-5) and the expression of recombinant human Parkinson's disease 7 (Park7) and to study the protective mechanism of tacrolimus (FK506) against MPC-5 injury.

methodsMPC-5 cells were cultured

resultsThe control group had a large number of foot processes of the cell body at all time points, with tight connections between cells and a normal morphology. Compared with the control group, the PAN group had a significantly smaller cell volume at all time points, with loose connections between cells and the presence of ruptured cells. Compared with the PAN group, the FK506 group had an increased cell volume at all time points, with tighter connections between cells and a better morphology. The PAN group had a significantly higher apoptosis rate than the control group at all time points. Compared with the PAN group, the FK506 group had a significant reduction in the apoptosis rate at all time points (

conclusionsPAN can act on MPC-5 cells and cause morphological and structural damage and apoptosis of MPC-5 cells, as well as upregulated mRNA and protein expression of Park7. FK506 can downregulate the mRNA and protein expression of Park7 in the model of MPC-5 injury, maintain cellular homeostasis, reduce proteinuria, and delay glomerulosclerosis.

Indexed as

Parkinson DiseasePodocytesAnimalsMiceProtein Deglycase DJ-1Puromycin AminonucleosideTacrolimusPARK7 protein, mouseProtein Deglycase DJ-1Puromycin AminonucleosideTacrolimusMouse podocyte clone 5Park7Puromycin aminonucleosideTacrolimus

Identifiers

PMID34535212
PMCPMC8480169
OpenAlexW3199853186

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.